IL113778A - Condensed-indan derivatives pharmaceutical compositions containing the same and methods for the preparation thereof - Google Patents

Condensed-indan derivatives pharmaceutical compositions containing the same and methods for the preparation thereof

Info

Publication number
IL113778A
IL113778A IL11377895A IL11377895A IL113778A IL 113778 A IL113778 A IL 113778A IL 11377895 A IL11377895 A IL 11377895A IL 11377895 A IL11377895 A IL 11377895A IL 113778 A IL113778 A IL 113778A
Authority
IL
Israel
Prior art keywords
group
substituted
optionally substituted
ring
nitrogenous heterocyclic
Prior art date
Application number
IL11377895A
Other languages
English (en)
Other versions
IL113778A0 (en
Original Assignee
Taiho Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Taiho Pharmaceutical Co Ltd filed Critical Taiho Pharmaceutical Co Ltd
Publication of IL113778A0 publication Critical patent/IL113778A0/xx
Publication of IL113778A publication Critical patent/IL113778A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D221/00Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/04Ortho- or peri-condensed ring systems
    • C07D221/18Ring systems of four or more rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Polyesters Or Polycarbonates (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL11377895A 1994-05-20 1995-05-18 Condensed-indan derivatives pharmaceutical compositions containing the same and methods for the preparation thereof IL113778A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP10719094 1994-05-20

Publications (2)

Publication Number Publication Date
IL113778A0 IL113778A0 (en) 1995-08-31
IL113778A true IL113778A (en) 1999-09-22

Family

ID=14452758

Family Applications (1)

Application Number Title Priority Date Filing Date
IL11377895A IL113778A (en) 1994-05-20 1995-05-18 Condensed-indan derivatives pharmaceutical compositions containing the same and methods for the preparation thereof

Country Status (21)

Country Link
US (3) US5733918A (de)
EP (1) EP0713870B1 (de)
KR (1) KR100190732B1 (de)
CN (1) CN1131216C (de)
AT (1) ATE203236T1 (de)
AU (1) AU685631B2 (de)
CA (1) CA2167382C (de)
DE (1) DE69521770T2 (de)
DK (1) DK0713870T3 (de)
ES (1) ES2158109T3 (de)
FI (1) FI111721B (de)
GR (1) GR3036795T3 (de)
HU (1) HU218308B (de)
IL (1) IL113778A (de)
NO (1) NO305555B1 (de)
NZ (1) NZ285448A (de)
PT (1) PT713870E (de)
RU (1) RU2124017C1 (de)
TW (1) TW440562B (de)
WO (1) WO1995032187A1 (de)
ZA (1) ZA954077B (de)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3141148B2 (ja) * 1995-08-08 2001-03-05 大鵬薬品工業株式会社 縮合インダン誘導体及びその塩
DE19538088A1 (de) * 1995-10-13 1997-04-17 Bernd Prof Dr Clement Phenanthridinderivate und ihre Herstellung
US20030096833A1 (en) * 2001-08-31 2003-05-22 Jagtap Prakash G. Substituted ideno[1,2-c]isoquinoline derivatives and methods of use thereof
US6956035B2 (en) * 2001-08-31 2005-10-18 Inotek Pharmaceuticals Corporation Isoquinoline derivatives and methods of use thereof
RU2315050C2 (ru) * 2001-10-05 2008-01-20 Ф.Хоффманн-Ля Рош Аг Полициклические соединения, обладающие противоопухолевой активностью
US6946472B2 (en) 2002-04-30 2005-09-20 Hoffman-La Roche Inc. Polycyclic compounds exhibiting anti-tumor activities
CL2004000366A1 (es) * 2003-02-26 2005-01-07 Pharmacia Corp Sa Organizada B USO DE UNA COMBINACION DE UN COMPUESTO DERIVADO DE PIRAZOL INHIBIDOR DE QUINASA p38, Y UN INHIBIDOR DE ACE PARA TRATAR DISFUNCION RENAL, ENFERMEDAD CARDIOVASCULAR Y VASCULAR, RETINOPATIA, NEUROPATIA, EDEMA, DISFUNCION ENDOTELIAL O INSULINOPATIA.
JP2007501857A (ja) * 2003-02-28 2007-02-01 イノテック ファーマシューティカルズ コーポレーション 四環系ベンズアミド誘導体およびその使用方法
EA200601558A1 (ru) * 2004-02-26 2007-08-31 Инотек Фармасьютикалз Корпорейшн Производные изохинолинов и способы их использования
US20050261288A1 (en) * 2004-02-26 2005-11-24 Prakash Jagtap Tetracyclic lactam derivatives and uses thereof
CA2571001A1 (en) * 2004-06-16 2006-01-26 Inotek Pharmaceuticals Corporation Methods for treating or preventing erectile dysfunction or urinary incontinence
WO2006091769A1 (en) * 2005-02-24 2006-08-31 Janssen Pharmaceutica N.V. Novel quinoline derivatives as potassium ion channel openers
WO2006093677A1 (en) * 2005-02-25 2006-09-08 Inotek Pharmaceuticals Corporation Tetracyclic sulfonamide compounds and methods of use thereof
JP2008531561A (ja) * 2005-02-25 2008-08-14 イノテック ファーマシューティカルズ コーポレイション イソキノリン化合物およびその使用方法
RU2007135362A (ru) * 2005-02-25 2009-03-27 Инотек Фармасьютикалз Корпорейшн (Us) Тетрациклические амино- и карбоксамидосоединения и способ их применения
CN101316592A (zh) * 2005-08-24 2008-12-03 伊诺泰克制药公司 茚并异喹啉酮类似物及其用法
MX2009009183A (es) * 2007-02-28 2009-09-07 Inotek Pharmaceuticals Corp Analogos de indenoisoquinolinona y metodos de utilizacion de los mismos.
CN103102304B (zh) * 2013-01-19 2015-03-11 安徽师范大学 N-磺酰基取代四氢异喹啉衍生物的制备方法
EP3037424B1 (de) 2013-08-22 2017-11-08 Taiho Pharmaceutical Co., Ltd. Neuartige chinolinsubstituierte verbindung
IL266239B2 (en) 2016-10-31 2023-10-01 Taiho Pharmaceutical Co Ltd A selective inhibitor of EGFR with an EXON 20 insertion mutation
HUE066587T2 (hu) 2017-09-01 2024-08-28 Taiho Pharmaceutical Co Ltd Exon-18- és/vagy exon-21-mutáns EGFR-szelektív inhibitor
EP4086290A1 (de) * 2021-05-04 2022-11-09 SHPP Global Technologies B.V. Gekapptes bisphenolpolyindanoligomer und zusammensetzung, verfahren zur herstellung und daraus hergestellte artikel

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60169482A (ja) * 1984-02-14 1985-09-02 Mitsubishi Chem Ind Ltd アミノ化フタライド−イソキノリン類の製法
JPH0633263B2 (ja) * 1985-05-27 1994-05-02 鐘淵化学工業株式会社 7−ヒドロキシグアニン誘導体及びその製造方法並びにそれを有効成分とする抗腫瘍剤
SU1574598A1 (ru) * 1987-11-03 1990-06-30 Институт Химической Кинетики И Горения Со Ан Ссср Способ получени 4-диалкиламино-2-алкил(или фенил)нафто[2,3- @ ]хинолин-7,12-дионов
US5223506A (en) * 1991-06-04 1993-06-29 Glaxo Inc. Cyclic antitumor compounds

Also Published As

Publication number Publication date
AU685631B2 (en) 1998-01-22
CA2167382C (en) 1999-08-31
WO1995032187A1 (en) 1995-11-30
NZ285448A (en) 1997-11-24
KR100190732B1 (ko) 1999-06-01
ATE203236T1 (de) 2001-08-15
KR960703864A (ko) 1996-08-31
FI960280A0 (fi) 1996-01-19
DE69521770D1 (de) 2001-08-23
EP0713870A1 (de) 1996-05-29
IL113778A0 (en) 1995-08-31
HU218308B (en) 2000-07-28
TW440562B (en) 2001-06-16
HUT75651A (en) 1997-05-28
EP0713870A4 (de) 1996-12-18
AU2454295A (en) 1995-12-18
CN1131216C (zh) 2003-12-17
ZA954077B (en) 1996-01-19
NO305555B1 (no) 1999-06-21
US5733918A (en) 1998-03-31
CA2167382A1 (en) 1995-11-30
FI111721B (fi) 2003-09-15
ES2158109T3 (es) 2001-09-01
NO960239L (no) 1996-03-18
DK0713870T3 (da) 2001-09-24
CN1130903A (zh) 1996-09-11
DE69521770T2 (de) 2002-05-23
NO960239D0 (no) 1996-01-19
US6028079A (en) 2000-02-22
RU2124017C1 (ru) 1998-12-27
EP0713870B1 (de) 2001-07-18
US5710162A (en) 1998-01-20
FI960280A7 (fi) 1996-03-18
PT713870E (pt) 2001-11-30
GR3036795T3 (en) 2002-01-31

Similar Documents

Publication Publication Date Title
IL113778A (en) Condensed-indan derivatives pharmaceutical compositions containing the same and methods for the preparation thereof
AU6052594A (en) New heterocyclic compounds
WO1991013055A3 (en) New aryl- and heteroarylethenylene derivatives and process for their preparation
ATE128975T1 (de) Harnstoffderivate, verfahren zu ihrer herstellung und diese enthaltende medikamente.
TW349098B (en) Naphthalene derivatives, process for the preparation thereof, and intermediates therefor
FI956270A0 (fi) Piperdiinijohdannaisia ja menetelmä niiden valmistamiseksi
NO940737L (de)
MX9804107A (es) Derivados de quinolina.
AU6129890A (en) Novel compounds
IL89929A0 (en) Beta-lactam derivatives,their preparation and pharmaceutical compositions containing them
HUT67283A (en) Method for producing n-containing fused heterocyclic ketone derivatives and medical preparatives containing them
MY128323A (en) Thiazole derivatives for inhibition of cytokine production and of cell adhesion
IE862630L (en) 3-VINYL AND 3-ETHYNYL-ß-CARBOLINES
HUT72434A (en) Novel pyridone carboxylic acid derivatives, pharmaceutical compositions containing them and processes for their production
AU6158486A (en) Dihydro pyridine derivatives
CA2166326A1 (en) Pyridazinone derivatives
CA2168563A1 (en) Benzopyrans and Pharmaceutical Compositions Containing Them
KR950704333A (ko) 신규한 세펨 유도체(novel cephem derivatives)
UA50722C2 (uk) Нітробензаміди, спосіб їх одержання (варіанти), фармацевтична композиція
WO2001022951A3 (en) Use of substituted 4-biarylbutyric and 5-biarylpentanoic acid derivatives for the treatment of multiple sclerosis
DE69634004D1 (de) Verknüpfte polycyclische heterocyclische verbindungen
EP0785191A4 (de) Kondensierte indanderivate und ihre salze
AU7332996A (en) Therapeutics for thrombocytopenia
CA2202031A1 (en) Condensed indan derivatives and salts thereof

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees